WT1 and prostate carcinoma: In our previous studies, we confirmed that recombinant B. longum displaying a mouse WT1 protein inhibited the tumor growth of mouse syngeneic prostate cancer cells in vivo and that its antitumor activity could be augmented by an anti-PD-1 antibody.25